Vered Bisker-Leib Net Worth & Insider Trades

Vered Bisker-Leib - Chief Operating Officer, Compass Therapeutics, Inc

As of November 25, 2022

What is Vered Bisker-Leib's Net Worth?

The current estimated net worth of Compass Therapeutics, Inc's Chief Operating Officer, Vered Bisker-Leib, is estimated to be about $3.32M . Vered Bisker-Leib owns about 1,060,414 units of Compass Therapeutics, Inc common stock. In the last year at Compass Therapeutics, Inc, Vered Bisker-Leib has sold an estimated value of $200.69K worth.

What is Vered Bisker-Leib's Past Insider Trading?

Vered Bisker-Leib's largest sale order was 24,500 units , worth over $103.71K on November 25, 2022. In total, Vered Bisker-Leib has made about 5 transactions over a year of their time at Compass Therapeutics, Inc. Vered Bisker-Leib usually trades in November, with the busiest year in 2022.

Vered Bisker-Leib

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Vered Bisker-Leib's Salary in 2020?

As Chief Operating Officer of Compass Therapeutics, Inc, Vered Bisker-Leib has a total base salary of $360,000 . Vered Bisker-Leib received compensation valued at about $2,571,579 in 2020 after becoming Chief Operating Officer. The vast majority of their compensation came in the form of a bonus of $160,000 , option awards of $2,051,579 .

What is Vered Bisker-Leib's' Mailing Address?

  • Mailing address is C/o Compass 245 First Street, 3rd Floor Cambridge MA 02142 MA

Compass Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Total
Thomas J. Schuetz, M.D., Ph.D. 2020 $4,000 - - $2,552,793 $2,556,793
Thomas J. Schuetz, M.D., Ph.D. 2019 $400,000 - $973,843 - $1,373,843
Vered Bisker-Leib, Ph.D., MBA 2020 $360,000 $160,000 - $2,051,579 $2,571,579
Vered Bisker-Leib, Ph.D., MBA 2019 $325,000 $160,875 $569,159 - $1,055,034
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1738021/000156459021021853/cmpx-def14a_20210603.htm

What are Compass Therapeutics, Inc's Past Insider Trades?

Compass Therapeutics, Inc's most recent insider trade came on November 25, 2022 by Vered Bisker-Leib who sold 24,500 units worth $103.71K . In the last year, insiders at Compass Therapeutics, Inc have sold an estimated value of $200.69K and bought an estimated value of $42.11M worth of shares. Insider trading is most common in May, with the busiest year in 2022. The most active traders at the company are Thomas J Schuetz, CHIEF EXECUTIVE OFFICER,  Carl Gordon, Director,  and Vered Bisker-Leib, Chief Operating Officer .

Compass Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1